FDA Approved: NELARABINE — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved the original application for Nelarabine from Zydus Lifesciences Limited, enabling generic access for treating T-cell acute lymphoblastic leukemia a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• Nelarabine (Nelarabine)

Snippet

ORIG AP for NELARABINE (NELARABINE)